Compugen Ltd. Share Price TEL AVIV STOCK EXCHANGE
Equities
CGEN
IL0010852080
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
680 ILa | +1.49% | -14.82% | -1.16% |
05-20 | Truist Securities Trims Price Target on Compugen to $4 From $5, Maintains Buy Rating | MT |
05-20 | Transcript : Compugen Ltd., Q1 2024 Earnings Call, May 20, 2024 |
Sales 2024 * | 37.04M 13.59B 2.91B | Sales 2025 * | 41.12M 15.08B 3.23B | Capitalization | 167M 61.09B 13.08B |
---|---|---|---|---|---|
Net income 2024 * | -4M -1.47B -314M | Net income 2025 * | -1M -367M -78.56M | EV / Sales 2024 * | 4.5 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 4.05 x |
P/E ratio 2024 * |
-37.2
x | P/E ratio 2025 * |
372
x | Employees | 68 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.62% |
Latest transcript on Compugen Ltd.
1 day | +1.49% | ||
1 week | -14.82% | ||
Current month | -7.77% | ||
1 month | -9.27% | ||
3 months | -23.66% | ||
6 months | +181.46% | ||
Current year | -1.16% |
Managers | Title | Age | Since |
---|---|---|---|
Anat Cohen-Dayag
CEO | Chief Executive Officer | 57 | 31/12/01 |
Alberto Sessa
DFI | Director of Finance/CFO | 61 | 31/10/22 |
Eran Ophir
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Paul Sekhri
CHM | Chairman | 65 | 01/10/17 |
Sanford Zweifach
BRD | Director/Board Member | 68 | 10/06/18 |
Gilead Halevy
BRD | Director/Board Member | 57 | 10/06/18 |
Date | Price | Change | Volume |
---|---|---|---|
22/05/24 | 680 | +1.49% | 4 362 |
21/05/24 | 670 | -4.30% | 387,220 |
20/05/24 | 700.1 | -9.62% | 107,818 |
19/05/24 | 774.6 | -3.01% | 32,867 |
16/05/24 | 798.6 | +0.04% | 84,446 |
Delayed Quote TEL AVIV STOCK EXCHANGE, May 22, 2024 at 09:57 am
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+44.48% | 55.07B | |
+43.85% | 40.22B | |
-0.86% | 41.79B | |
-7.59% | 28.17B | |
+12.30% | 26.28B | |
-21.83% | 18.93B | |
+7.15% | 13.03B | |
+29.40% | 12.26B | |
+25.15% | 12.21B |
- Stock Market
- Equities
- CGEN Stock
- CGEN Stock